BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37340924)

  • 1. [The role of group 2 innate lymphoid cells (ILC2) in respiratory allergic diseases: An update].
    Luo C; Liu S; Ren Q; Peng S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun; 39(6):552-557. PubMed ID: 37340924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice.
    LeSuer WE; Kienzl M; Ochkur SI; Schicho R; Doyle AD; Wright BL; Rank MA; Krupnick AS; Kita H; Jacobsen EA
    J Allergy Clin Immunol; 2023 Aug; 152(2):469-485.e10. PubMed ID: 37028525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.
    van Rijt L; von Richthofen H; van Ree R
    Semin Immunopathol; 2016 Jul; 38(4):483-96. PubMed ID: 26965110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target.
    Jin J; Sunusi S; Lu H
    J Int Med Res; 2022 Jan; 50(1):3000605211053156. PubMed ID: 35048721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells and type 2 innate lymphoid cell-dependent asthma.
    Aron JL; Akbari O
    Allergy; 2017 Aug; 72(8):1148-1155. PubMed ID: 28160290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
    Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
    Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group 2 innate lymphoid cells (ILC2s): The spotlight in asthma pathogenesis and lung tissue injury.
    Sadik S; Lu Y; Zhu S; Cai J; Mi LL
    Allergol Immunopathol (Madr); 2021; 49(2):208-216. PubMed ID: 33641310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine and Lipid Mediator Regulation of Group 2 Innate Lymphoid Cells (ILC2s) in Human Allergic Airway Disease.
    Cavagnero K; Doherty TA
    J Cytokine Biol; 2017 Aug; 2(2):. PubMed ID: 28959799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are ILC2s Jekyll and Hyde in airway inflammation?
    Ealey KN; Moro K; Koyasu S
    Immunol Rev; 2017 Jul; 278(1):207-218. PubMed ID: 28658554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group 2 Innate Lymphoid Cells in Airway Diseases.
    Kato A
    Chest; 2019 Jul; 156(1):141-149. PubMed ID: 31082387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of type 2 innate lymphoid cell and its related cytokines in tumor immunity.
    Wan J; Cai W; Wang H; Cheng J; Su Z; Wang S; Xu H
    J Cell Physiol; 2020 Apr; 235(4):3249-3257. PubMed ID: 31625163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9
    Verma M; Liu S; Michalec L; Sripada A; Gorska MM; Alam R
    J Allergy Clin Immunol; 2018 Sep; 142(3):793-803.e8. PubMed ID: 29132961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate Lymphoid Cells in Airway Inflammation.
    Asghar Pasha M; Yang Q
    Adv Exp Med Biol; 2021; 1303():183-191. PubMed ID: 33788194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice.
    Li BWS; de Bruijn MJW; Lukkes M; van Nimwegen M; Bergen IM; KleinJan A; GeurtsvanKessel CH; Andeweg A; Rimmelzwaan GF; Hendriks RW
    Eur J Immunol; 2019 Jan; 49(1):144-156. PubMed ID: 29762870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma.
    Matsuyama T; Matsuyama H; Dotake Y; Takagi K; Machida K; Inoue H
    Front Immunol; 2022; 13():930862. PubMed ID: 35911708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ILCs and Allergy.
    Kabata H; Motomura Y; Kiniwa T; Kobayashi T; Moro K
    Adv Exp Med Biol; 2022; 1365():75-95. PubMed ID: 35567742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
    Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
    Front Immunol; 2021; 12():664218. PubMed ID: 34867937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease.
    Karta MR; Broide DH; Doherty TA
    Curr Allergy Asthma Rep; 2016 Jan; 16(1):8. PubMed ID: 26746844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.
    Thio CL; Chi PY; Lai AC; Chang YJ
    J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase Cθ controls type 2 innate lymphoid cell and T
    Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
    J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.